Latest news and press releases about AngioDynamics, Inc. (ANGO): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets.
Price
| Price | $15.46 |
| Market Cap | $639M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.75 |
| EV / EBITDA | -16.04 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -21.01% |
| Return on Invested Capital | -20.75% |
| Return on Assets | -13.75% |
| Gross Margin | 54.62% |
| Operating Margin | -12.47% |
| Net Margin | -11.48% |
Related companies: CGEM · FULC · LAB · NMRA · OCGN · OMER · RAPT
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of ANGO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks